The detection rates of mutations of KRAS, TP53, CDKN2A, and SMAD4.
figure
posted on 2020-01-30, 18:40 authored by Tetsuya Ishizawa, Naohiko Makino, Akiko Matsuda, Yasuharu Kakizaki, Toshikazu Kobayashi, Chisaki Ikeda, Shinpei Sugahara, Michihiko Tsunoda, Yoshiyuki UenoThe detection rates of mutations of KRAS, TP53, CDKN2A, and SMAD4.
History
Usage metrics
Categories
Keywords
KRAS mutation analysisretrospective study Pancreatic cancer2A2017. DNA sequencescancer gene panel testingSMADCDKNendoscopic ultrasound-guided fine-needle aspirationpolymerase chain reactionNGSROSE specimensunresectable PC patients5- year survival rateKRAS mutationsTPIon AmpliSeq Comprehensive Caner Panel
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC